Showing 5101-5110 of 5621 results for "".
- QuickSee Handheld Autorefractor Shows Strong Agreement With Subjective Refraction Measurementshttps://modernod.com/news/quicksee-handheld-autorefractor-shows-strong-agreement-with-subjective-refraction-measurements/2476968/PlenOptika, maker of the QuickSee handheld autorefractor, announced the publication of research showing their device produces measurements in strong agreement with subjective refraction and traditional autorefraction technology. The paper “<
- AAO and Verana Health Accelerate Clinical Trials for Patients with Rare, Sight-Threatening Retinal Diseases Through Verana Trial Connecthttps://modernod.com/news/aao-and-verana-health-accelerate-clinical-trials-for-patients-with-rare-sight-threatening-retinal-diseases-through-verana-trial-connect/2476962/The American Academy of Ophthalmology (AAO) and Verana Health announced that they are now facilitating no-cost genetic testing and counseling for patients with certain inherited retinal diseases through Verana Trial Connect, a powerful cloud-based application that facilitates physician and patien
- Allegro to Present Clinical Research on the Novel Integrin-Regulating Portfolio at AAOhttps://modernod.com/news/allegro-to-present-clinical-research-on-the-novel-integrin-regulating-portfolio-at-aao/2476956/Allegro Ophthalmics announced that the results of its phase 2 clinical study of risuteganib (Luminate) for the treatment of intermediate nonexudative age-related macular degeneration (AMD) will be presented during AAO
- LensGen to Review Latest Juvene IOL Results At AAOhttps://modernod.com/news/lensgen-to-review-latest-juvene-iol-results-at-aao/2476954/LensGen will review its latest data for the world’s first modular fluid optic IOL in several activities around the American Academy of Ophthalmology (AAO) annual meeting in San Francisco this week. LensGen developed Juvene, which uses biomimetic design princ
- Novartis Receives FDA Approval for Beovu for Wet AMDhttps://modernod.com/news/novartis-receives-fda-approval-for-beovu-for-wet-amd/2476953/Novartis announced that the FDA approved Beovu (brolucizumab-dbll) injection, also known as RTH258, for the treatment of wet age-related macular degeneration (AMD). Beovu is the first FDA approved anti-VEGF to offer both greater fluid resolution versus aflibercept and the ability to maintain elig
- Johnson & Johnson Vision Launches Worldwide #ConnectedBySight Campaign in Honor of World Sight Dayhttps://modernod.com/news/johnson-johnson-vision-launches-worldwide-connectedbysight-campaign-in-honor-of-world-sight-day/2476949/In honor of World Sight Day on October 10, 2019, Johnson & Johnson Vision has launched a worldwide campaign to share the untold stories of eye care professionals, patients, and organizations who are inspiring the elevation of eye health as a global priority and demonstrating how the world is
- Oculis Announces Dosing of First Patient in Randomized Phase 2b (SKYGGN) Clinical Trial of OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgeryhttps://modernod.com/news/oculis-announces-dosing-of-first-patient-in-randomized-phase-2b-skyggn-clinical-trial-of-ocs-01-for-the-treatment-of-inflammation-and-pain-following-cataract-surgery/2476947/Oculis announced the dosing of the first patient in a phase 2b clinical trial evaluating the efficacy and safety of OCS-01 for the treatment of inflammation and pain following cataract surgery. OCS-01 is a unique topical formulation of dexamethasone based on the company’s proprietary
- TECLens and SERVImed Industrial Spa Announce Partnership to Pursue FDA Approval for Transepithelial Corneal Cross-Linkinghttps://modernod.com/news/teclens-and-servimed-industrial-spa-announce-partnership-to-pursue-fda-approval-for-trans-epithelial-corneal-cross-linking/2476941/Medical device manufacturer TECLens announced a partnership with Italian medical device maker SERVimed Industrial Spa aimed at the development and FDA approval of a new combination product to treat keratoconus. The ne
- Optovue to Introduce NetVue Cloud Image Management Solutions at AAOhttps://modernod.com/news/optovue-introduces-netvue-cloud-image-management-solutions-at-aao/2476940/Optovue announced it will introduce NetVue Cloud image management software at the annual AAO meeting in San Francisco. The NetVue software provides quick access to patients’ images and data on a single screen, eliminating the need to open device-specific app
- Johnson & Johnson Vision Care Introduces Acuvue RevitaLens Multi-Purpose Disinfecting Solutionhttps://modernod.com/news/johnson-johnson-vision-care-introduces-acuvue-revitalens-multi-purpose-disinfecting-solution/2476925/Johnson & Johnson Vision has unveiled the first extension of the Acuvue brand name beyond contact lenses with the launch of Acuvue RevitaLens Multi-Purpose Disinfecting Solution (MPDS). Acuvue RevitaLens MPDS delivers disinfection and all-day comfort for reusable contact lens wearers. Its dua